Opinions/blogs

Hear about different aspects of dementia research from a range of researchers, healthcare professionals and volunteers

The non-approval of aducanumab in Europe still marks a significant stride forward in dementia research

17 December 2021

An opinion piece by Professor John O’Brien, NIHR Clinical Research Network National Specialty Lead for Dementias The European Medicines Agency (EMA) has today said no to approving aducanumab – a new drug to treat Alzheimer’s disease. EMA considered that although the drug removed amyloid, a toxic protein that builds up in the brains of people […]

Air pollution and dementia

29 July 2021

The possible link between air pollution and dementia has been a focus of several studies and at the recent US Alzheimer’s Association International Conference (AAIC), the topic came to the fore again.  New findings Whilst previous reports have linked long-term air pollution exposure with accumulation of Alzheimer’s disease-related brain plaques, a series of new reports […]

Now that COVID restrictions are gradually lifting, what’s next for dementia research?

15 June 2021

An opinion piece by Professor Alistair Burns,  National Clinical Director for Dementia at NHS England and Professor Martin Rossor, NIHR National Director for Dementia Research.   During the lockdowns, many of the activities that we know are good for our brain health such as socialising, exercising and other cultural experiences were made more difficult. This […]

Guest blog: Dementia Action Week 2019 | Taking the next step together

21 May 2019

Professor Martin Rossor, NIHR National Director for Dementia Research

In this blog for Dementia Action Week, Professor Martin Rossor reflects on how far dementia research has come, and looks ahead to how healthcare professionals, researchers and the public can take the next step together.